In breast cancer, although GPS1 has been shown to be associated with WBP2-mediated activation of the Wnt signaling pathway (Li et al. 2018), its specific molecular regulatory mechanism in breast cancer is unclear. This evidence concerns the gene GPS1 and breast carcinoma.